K983697

Substantially Equivalent

MODIFICATION TO ABUSCREEN ONLINE COCAINE METABOLITE

Applicant: Roche Diagnostic Systems, Inc.
Product code: DIO
Advisory panel: Clinical Toxicology
Date received: 1998-10-21
Decision date: 1998-12-11
Decision: Substantially Equivalent
Clearance type: Special
Location: Somerville, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.